on September 15, 2005
Published online before print September 15, 2005, doi: 10.1161/01.STR.0000182241.07096.06
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on April 13, 2005
From the Department of Neurology, Juntendo University School of Medicine, Bunkyo-ku, Tokyo, Japan. * To whom correspondence should be addressed. E-mail: t_urabe{at}med.juntendo.ac.jp.
Background and Purpose--Oxidative stress contributes to ischemia/reperfusion neuronal damage in a consecutive 2-phase pattern: an immediate direct cytotoxic effect and subsequent redox-mediated inflammatory insult. The present study was designed to assess the neuroprotective mechanisms of edaravone, a novel free radical scavenger, through antioxidative and anti-inflammatory pathways, from the early period to up to 7 days after ischemia/reperfusion in mice. Methods--Mice were subjected to 60-minute ischemia followed by reperfusion. They were divided into the edaravone group (n=72; with different schedules for first administration) and the vehicle (control) group (n=36). Infarct volume and neurological deficit scores were evaluated at several time points after ischemia. Immunohistochemical analysis for 4-hydroxy-2-nonenal (HNE), 8-hydroxy-deoxyguanosine (8-OHdG), ionized calcium-binding adapter molecule 1 (Iba-1), inducible NO synthase (iNOS), and nitrotyrosine were performed at 24 hours, 72 hours, or 7 days after reperfusion. Result--Edaravone, even when administrated 6 hours after onset of ischemia/reperfusion, significantly reduced the infarct volume (68.10±6.24%; P<0.05) and improved the neurological deficit scores (P<0.05) at 24 hours after reperfusion. Edaravone markedly suppressed the accumulation of HNE-modified protein and 8-OHdG at the penumbra area during the early period after reperfusion (P<0.05) and reduced microglial activation, iNOS expression, and nitrotyrosine formation at the late period. Conclusion--Our results indicated that edaravone exerts an early neuroprotective effect through the early free radicals scavenging pathway and a late anti-inflammatory effect and suggested that edaravone is important for expansion of the therapeutic time window in stroke patients.
Accepted on June 7, 2005
Edaravone Reduces Early Accumulation of Oxidative Products and Sequential Inflammatory Responses After Transient Focal Ischemia in Mice Brain
Ning Zhang MD;
Key words: ischemia • lipid peroxidation • microglia • nitric oxide synthase • reperfusion injury
This article has been cited by other articles:
 |
|
 |
|
  K. Kikuchi, K.-i. Kawahara, S. Tancharoen, F. Matsuda, Y. Morimoto, T. Ito, K. K. Biswas, K. Takenouchi, N. Miura, Y. Oyama, et al. The Free Radical Scavenger Edaravone Rescues Rats from Cerebral Infarction by Attenuating the Release of High-Mobility Group Box-1 in Neuronal Cells J. Pharmacol. Exp. Ther., June 1, 2009; 329(3): 865 - 874. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Inokuchi, S. Imai, Y. Nakajima, M. Shimazawa, M. Aihara, M. Araie, and H. Hara Edaravone, a Free Radical Scavenger, Protects against Retinal Damage in Vitro and in Vivo J. Pharmacol. Exp. Ther., May 1, 2009; 329(2): 687 - 698. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Oyamada, M. Sone, K. Miyashita, K. Park, D. Taura, M. Inuzuka, T. Sonoyama, H. Tsujimoto, Y. Fukunaga, N. Tamura, et al. The Role of Mineralocorticoid Receptor Expression in Brain Remodeling after Cerebral Ischemia Endocrinology, August 1, 2008; 149(8): 3764 - 3777. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Murano, M. Ishizaki, S. Sato, Y. Fukuda, and H. Takahashi Corneal Endothelial Cell Damage by Free Radicals Associated With Ultrasound Oscillation Arch Ophthalmol, June 1, 2008; 126(6): 816 - 821. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Arai, M. Nonogawa, K. Makino, N. Endo, H. Mori, T. Miyoshi, K. Yamashita, M. Sasada, M. Kakuyama, and K. Fukuda The Radical Scavenger Edaravone (3-Methyl-1-phenyl-2-pyrazolin-5-one) Reacts with a Pterin Derivative and Produces a Cytotoxic Substance That Induces Intracellular Reactive Oxygen Species Generation and Cell Death J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 529 - 538. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Wakade, M. M. Khan, L. M. De Sevilla, Q.-G. Zhang, V. B. Mahesh, and D. W. Brann Tamoxifen Neuroprotection in Cerebral Ischemia Involves Attenuation of Kinase Activation and Superoxide Production and Potentiation of Mitochondrial Superoxide Dismutase Endocrinology, January 1, 2008; 149(1): 367 - 379. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Shi, X. Jiang, T. Kazui, N. Washiyama, K. Yamashita, H. Terada, and A. H. M. Bashar Controlled low-pressure perfusion at the beginning of reperfusion attenuates neurologic injury after spinal cord ischemia J. Thorac. Cardiovasc. Surg., April 1, 2007; 133(4): 942 - 948. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Suzuki, T. Kazui, S. Yamamoto, N. Washiyama, K. Ohkura, K. Ohishi, A. H. M. Bashar, K. Yamashita, H. Terada, K. Suzuki, et al. Effect of prophylactically administered edaravone during antegrade cerebral perfusion in a canine model of old cerebral infarction J. Thorac. Cardiovasc. Surg., March 1, 2007; 133(3): 710 - 716. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Zona, M. Pieri, and I. Carunchio Voltage-Dependent Sodium Channels in Spinal Cord Motor Neurons Display Rapid Recovery From Fast Inactivation in a Mouse Model of Amyotrophic Lateral Sclerosis J Neurophysiol, December 1, 2006; 96(6): 3314 - 3322. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Watanabe, N. Zhang, M. Liu, R. Tanaka, Y. Mizuno, and T. Urabe Cilostazol Protects Against Brain White Matter Damage and Cognitive Impairment in a Rat Model of Chronic Cerebral Hypoperfusion Stroke, June 1, 2006; 37(6): 1539 - 1545. [Abstract] [Full Text] [PDF]
|
|